Cbl is an adaptor protein that functions as a negative regulator of many si
gnalling pathways that start from receptors at the cell surface(1-4). The e
volutionarily conserved amino-terminal region of Cbl (Cbl-N) binds to phosp
horylated tyrosine residues and has cell-transforming activity. Point mutat
ions in Cbl, that disrupt its recognition of phosphotyrosine also interfere
with its negative regulatory function and, in the case of v-cbl, with its
oncogenic potential(5). In T cells, Cbl-N binds to the tyrosine-phosphoryla
ted inhibitory site of the protein tyrosine kinase ZAP-70(6). Here we descr
ibe the crystal structure of Cbl-N, both alone and in complex with a phosph
opeptide that represents its binding site in ZAP-70. The structures show th
at Cbl-N is composed of three interacting domains: a four-helix bundle (4H)
, an EF-hand(7) calcium-binding domain, and a divergent SH2 domain(8) that
was not recognizable from the amino-acid sequence of the protein. The calci
um-hound EF hand wedges between the 4H and SH2 domains and roughly determin
es their relative orientation. In the ligand-occupied structure, the 4H dom
ain packs against the SH2 domain and completes its phosphotyrosine-recognit
ion pocket. Disruption of this binding to ZAP-70 as a result of structure-b
ased mutations in the 4H, EF-hand and SH2 domains confirms that the three d
omains together form an integrated phosphoprotein-recognition module.